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Introduction: Epilepsy is a complex disorders of central nervous system (CNS) which
exist as a form of recurrent chronic convulsions . Unfortunatly, there are many adverse
effects for most of current anti-epieptic drugs and the need for intriduction of new drugs
is tangible. There are reports about the anticonvlsant activity of some 6-chloro
benzothtazolll-2-thiosemicarbazones. Because of close similarities between 6-chloro
benzothiazol amine and [1,3,4]-thiabiyazolamine with aryl substitutions in position 5, it
can be imaginated that fl,3,4l-thiadiyazolamin thiosemicarb.Lzones compounds with a
zusbstitution in position 5 of thiadiyazol ring could bear good anticonvulant properties.
Materials and Methods: Four new derivatives of 3-isatinyl-2-thiadiazole
thiosemicarbazone synthesized by the medicinal chemist were evaluated in the animal
convulsion model of peirtylentel;razol (PTZ) in mice. Dose 50 mg/kg of the derivatives,
solvent (10 ml/kg as negative control) and ethosuximide (150 mg/kg as positive control)
were injected intraperitoneally to the groups of male NMRI mice and after 30 minutes a
convulsive dose of PTZ whch could induce Hind Limb Tonic Extension ftILTE) in
IOO% of untreated mice was injected to the mice. Incidence of HLTE, mortality, clonic
latency time and tonic latency time items were registered in different groups and
compared with the control group.
Results: The solubility of the derivatives were investigated in different non-toxic
solvents and finally 2%o.DMSO in sesame oil was cosidered as the best solvent. During
ry u4*t +)o
the process of finding the good solvent, compound I was finished and compounds-Il, -
Itr, and [V were further evaluated in the PTZ model. Because of little solubility of
derivatives in the solvent and small amount of the derivatives, only dose of 50 mg/kg of
the compounds was evaluated. None of the compounds could decrease the incidence of
HLTE, mortality rate, and the onset of clonic convulsions in comparision to the control
group. Only compound-Ill could significantly delay the tonic convulsions.
Conclusions: The studied 3-isatinyl-2-thiadiazole thiosemicarbazone derivatives dd not
have anticonvulsant activity in the PTZ model in non-neurotoxic dose. Study on the
other derivatives of 3-isatinyl-2-thiadiazole thiosemicarbazone as anticonvulsive
compounds is recommended.
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